A dual CCR2/CCR5 chemokine antagonist, BMS-813160? Evaluation of WO2011046916.
about
Targeting chemokines in proteinuria-induced renal disease.Progress in the discovery of CC chemokine receptor 2 antagonists, 2009 - 2012.Novel avenues for treating diabetic nephropathy: new investigational drugs.Dual CCR2/5 Antagonist Attenuates Obesity-Induced Insulin Resistance by Regulating Macrophage Recruitment and M1/M2 Status.Small Molecules Drive Big Improvements in Immuno-Oncology Therapies.
P2860
A dual CCR2/CCR5 chemokine antagonist, BMS-813160? Evaluation of WO2011046916.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
A dual CCR2/CCR5 chemokine antagonist, BMS-813160? Evaluation of WO2011046916.
@en
A dual CCR2/CCR5 chemokine antagonist, BMS-813160? Evaluation of WO2011046916.
@nl
type
label
A dual CCR2/CCR5 chemokine antagonist, BMS-813160? Evaluation of WO2011046916.
@en
A dual CCR2/CCR5 chemokine antagonist, BMS-813160? Evaluation of WO2011046916.
@nl
prefLabel
A dual CCR2/CCR5 chemokine antagonist, BMS-813160? Evaluation of WO2011046916.
@en
A dual CCR2/CCR5 chemokine antagonist, BMS-813160? Evaluation of WO2011046916.
@nl
P2860
P1476
A dual CCR2/CCR5 chemokine antagonist, BMS-813160? Evaluation of WO2011046916.
@en
P2093
Peter Norman
P2860
P304
P356
10.1517/13543776.2011.622750
P407
P577
2011-09-22T00:00:00Z